Hussman Strategic Advisors, Inc. Vericel Corp Transaction History

Hussman Strategic Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Sep 12, 2022	SELL	$22.88 - $39.45 $141,856 - $244,590	-6,200 Closed	0 $0
Q2 2021 Aug 03, 2021	BUY	$47.2 - $67.81 $292,640 - $420,422	6,200 New	6,200 $326,000
Q4 2019 Jan 31, 2020	SELL	$13.77 - $19.2 $55,080 - $76,800	-4,000 Closed	0 $0
Q3 2019 Oct 31, 2019	BUY	$14.93 - $19.83 $59,720 - $79,320	4,000 New	4,000 $61,000

276

48.5M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.67B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.